abstract |
The present invention relates to the use of inactivated parapoxvirus in the prevention and treatment of diseases associated with increased collagen deposition which also affects internal organs such as the liver and the skin and their accessory structures. In particular, the present invention relates to liver fibrosis after hepatitis virus infection and to use in cirrhosis or liver disease induced by ethanol, for example cystic fibrosis. |